[Modulating effect of mu-opioid receptor ligands on adrenergic mechanism of stressor heart damage pathogenesis].
Lishmanov
Iu B
IuB
Naryzhnaia
N V
NV
Revinskaia
Iu G
IuG
Maslov
L N
LN
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D011756:Diphosphates / Q000378:metabolism; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004745:Enkephalins / Q000494:pharmacology; D007103:Immobilization; D008024:Ligands; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017450:Receptors, Opioid, mu / Q000819:agonists*; D013312:Stress, Physiological / Q000378:metabolism*
D002395:Catecholamines; D011756:Diphosphates; D004745:Enkephalins; D008024:Ligands; D009842:Oligopeptides; D017450:Receptors, Opioid, mu; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; C063076:tyrosyl-arginyl-phenylalanyl-lysinamide